搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
育儿小课堂 on MSN
12 天
全国首例!一新生儿先天性门体静脉分流介入封堵术成功
三峡日报讯(通讯员焦盼)近日,宜昌市中心人民医院小儿外科成功完成一例新生儿罕见畸形病例先天性门体静脉分流的介入治疗,现患儿已康复出院。
3 天
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate ...
5 天
on MSN
Researchers identify potential new strategy to slow the development of liver fibrosis
A study led by Manuel Vázquez Carrera, group leader at the Diabetes and Associated Metabolic Diseases Networking Biomedical ...
13 天
会声会影 | 全国小儿外科学术年会闭幕,我中心学术成果再获赞誉!
泌尿外科团队群英荟萃,在手术技术创新和疾病诊疗方面同样取得了显著成果。贾炜主任在泌尿外科专场做了《女性尿道上裂合并尿失禁经会阴一期改良手术效果报告》的专题报告, 刘国昌主任《以尿道口为基底斜行带蒂皮瓣一期修复重度尿道下裂》展示了团队在尿道下裂修复领域的精湛技艺。
BCBusiness
3 天
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk
The agreement with NanoVation marks the second big recent deal that a B.C. biotech startup has struck with the Danish ...
5 天
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate ...
Vancouver
3 天
Vancouver biotech inks $800M partnership with Novo Nordisk
NanoVation Therapeutics, a Vancouver company co-founded by biotech magnate Pieter Cullis, has struck a partnership with ...
Nature
3 个月
Technology Insight: advances in liver imaging
Such studies would have to compare investigations of the entire abdomen, since hepatic examination with contrast ultrasonography does not detect extrahepatic metastases. Finally, at present ...
Endovascular Today
6 天
Delcath Systems Hepzato Kit for mUM Evaluated in Subgroup Analysis of FOCUS Trial
Delcath Systems, Inc. announced the presentation of new subgroup analysis data from the phase 3 FOCUS trial of Hepzato Kit (m ...
News Medical on MSN
5 天
Activation of PPARβ/δ-AMPK pathway shown to slow liver fibrosis development
A study led by Manuel Vázquez Carrera, group leader at the Diabetes and Associated Metabolic Diseases Networking Biomedical ...
3 天
Jazz Pharmaceuticals: Zanidatamab Is A Potential Growth Catalyst
Jazz Pharma's diversified drug portfolio drives revenue growth. Zanidatamab shows promise with potential FDA approval in late ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈